Jun 17, 2026 07:00AM
Jun 1, 2026 11:11AM
May 19, 2026 03:14PM
May 3, 2026 08:00PM
Apr 17, 2026 02:00PM
Apr 17, 2026 02:00PM
Apr 15, 2026 07:00AM UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
Apr 13, 2026 07:00AM
Mar 27, 2026 09:00AM
Mar 27, 2026 09:00AM
Mar 24, 2026 02:46PM
Mar 11, 2026 07:00AM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
Dec 4, 2025 08:12AM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Oct 29, 2025 12:00PM
Oct 29, 2025 07:00AM
Oct 25, 2025 11:00AM BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
Oct 13, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 10, 2025 08:00AM
Aug 29, 2025 01:15AM
Aug 5, 2025 08:00AM
Jul 8, 2025 07:00AM UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
Jun 27, 2025 07:00AM
Jun 20, 2025 07:00AM
Jun 17, 2025 08:22AM
Jun 12, 2025 12:30PM
Jun 12, 2025 01:00AM
Jun 11, 2025 12:16PM
May 19, 2025 12:30PM UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences
Apr 3, 2025 07:00AM
Mar 19, 2025 07:00AM
Mar 12, 2025 01:54PM
Mar 7, 2025 08:00AM
Mar 7, 2025 08:00AM
Feb 27, 2025 07:00AM
Jan 16, 2025 07:00AM UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx)
Dec 6, 2024 12:00PM
Nov 26, 2024 07:00AM
Nov 20, 2024 07:00AM
Nov 19, 2024 01:00AM
Nov 14, 2024 12:46PM
Oct 11, 2024 07:00AM
Sep 30, 2024 07:00AM UCB Announces a Head-to-Head Study Evaluating BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in Active Psoriatic Arthritis
Sep 27, 2024 07:00AM

1,160,149 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All